A seasoned fund manager with extensive expertise in technology and healthcare sectors, the individual has successfully executed over 30 deals across North America and Europe. Prioritizing early-stage investments, they adopt a data-driven approach to identify promising startups. Their strategic style emphasizes operator-first engagement, which has led to several notable exits, including a high-profile acquisition in the biotech field. This background equips them with a robust understanding of market dynamics and a keen eye for scalable opportunities.